CRVS
Price
$20.84
Change
-$0.50 (-2.34%)
Updated
Feb 4, 04:59 PM (EDT)
Capitalization
1.79B
29 days until earnings call
Intraday BUY SELL Signals
KRRO
Price
$12.26
Change
-$0.44 (-3.46%)
Updated
Feb 4, 04:59 PM (EDT)
Capitalization
119.6M
Intraday BUY SELL Signals
Interact to see
Advertisement

CRVS vs KRRO

Header iconCRVS vs KRRO Comparison
Open Charts CRVS vs KRROBanner chart's image
Corvus Pharmaceuticals
Price$20.84
Change-$0.50 (-2.34%)
Volume$24.56K
Capitalization1.79B
Korro Bio
Price$12.26
Change-$0.44 (-3.46%)
Volume$2.76K
Capitalization119.6M
CRVS vs KRRO Comparison Chart in %
CRVS
Daily Signal:
Gain/Loss:
KRRO
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CRVS vs. KRRO commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRVS is a Buy and KRRO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (CRVS: $21.34 vs. KRRO: $12.70)
Brand notoriety: CRVS and KRRO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRVS: 35% vs. KRRO: 72%
Market capitalization -- CRVS: $1.79B vs. KRRO: $119.6M
CRVS [@Biotechnology] is valued at $1.79B. KRRO’s [@Biotechnology] market capitalization is $119.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRVS’s FA Score shows that 1 FA rating(s) are green whileKRRO’s FA Score has 1 green FA rating(s).

  • CRVS’s FA Score: 1 green, 4 red.
  • KRRO’s FA Score: 1 green, 4 red.
According to our system of comparison, CRVS is a better buy in the long-term than KRRO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRVS’s TA Score shows that 4 TA indicator(s) are bullish while KRRO’s TA Score has 5 bullish TA indicator(s).

  • CRVS’s TA Score: 4 bullish, 6 bearish.
  • KRRO’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, KRRO is a better buy in the short-term than CRVS.

Price Growth

CRVS (@Biotechnology) experienced а -3.35% price change this week, while KRRO (@Biotechnology) price change was +18.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.56%. For the same industry, the average monthly price growth was +1.40%, and the average quarterly price growth was +33.10%.

Reported Earning Dates

CRVS is expected to report earnings on Mar 05, 2026.

Industries' Descriptions

@Biotechnology (-2.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRVS($1.79B) has a higher market cap than KRRO($120M). CRVS YTD gains are higher at: 177.143 vs. KRRO (58.552). CRVS has higher annual earnings (EBITDA): -38.76M vs. KRRO (-89.62M). KRRO has more cash in the bank: 92.5M vs. CRVS (65.7M). CRVS has less debt than KRRO: CRVS (1.01M) vs KRRO (44.7M). KRRO has higher revenues than CRVS: KRRO (7.37M) vs CRVS (0).
CRVSKRROCRVS / KRRO
Capitalization1.79B120M1,490%
EBITDA-38.76M-89.62M43%
Gain YTD177.14358.552303%
P/E RatioN/AN/A-
Revenue07.37M-
Total Cash65.7M92.5M71%
Total Debt1.01M44.7M2%
FUNDAMENTALS RATINGS
CRVS vs KRRO: Fundamental Ratings
CRVS
KRRO
OUTLOOK RATING
1..100
8928
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
20
Undervalued
PROFIT vs RISK RATING
1..100
21100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
3457
P/E GROWTH RATING
1..100
99100
SEASONALITY SCORE
1..100
n/a90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KRRO's Valuation (20) in the null industry is somewhat better than the same rating for CRVS (78) in the Pharmaceuticals Major industry. This means that KRRO’s stock grew somewhat faster than CRVS’s over the last 12 months.

CRVS's Profit vs Risk Rating (21) in the Pharmaceuticals Major industry is significantly better than the same rating for KRRO (100) in the null industry. This means that CRVS’s stock grew significantly faster than KRRO’s over the last 12 months.

CRVS's SMR Rating (97) in the Pharmaceuticals Major industry is in the same range as KRRO (100) in the null industry. This means that CRVS’s stock grew similarly to KRRO’s over the last 12 months.

CRVS's Price Growth Rating (34) in the Pharmaceuticals Major industry is in the same range as KRRO (57) in the null industry. This means that CRVS’s stock grew similarly to KRRO’s over the last 12 months.

CRVS's P/E Growth Rating (99) in the Pharmaceuticals Major industry is in the same range as KRRO (100) in the null industry. This means that CRVS’s stock grew similarly to KRRO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRVSKRRO
RSI
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
75%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 6 days ago
84%
Declines
ODDS (%)
Bearish Trend 8 days ago
89%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
CRVS
Daily Signal:
Gain/Loss:
KRRO
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HPQFF0.140.01
+8.44%
HPQ SILICON INC
BOUYF48.49N/A
N/A
Bouygues SA
HBGRY1.07N/A
N/A
Heidelberger Druckmaschinen AG
JCDXF20.76N/A
N/A
JC Decaux SA
TERS0.05N/A
-4.67%
Tersis Technologies Inc.

CRVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRVS has been loosely correlated with ACRS. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if CRVS jumps, then ACRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRVS
1D Price
Change %
CRVS100%
+1.72%
ACRS - CRVS
65%
Loosely correlated
-3.88%
RAPT - CRVS
46%
Loosely correlated
+0.12%
RZLT - CRVS
41%
Loosely correlated
-2.78%
AMLX - CRVS
36%
Loosely correlated
-1.23%
KRRO - CRVS
36%
Loosely correlated
-2.68%
More

KRRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, KRRO has been loosely correlated with APLT. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if KRRO jumps, then APLT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KRRO
1D Price
Change %
KRRO100%
-2.68%
APLT - KRRO
57%
Loosely correlated
N/A
MGNX - KRRO
44%
Loosely correlated
N/A
FULC - KRRO
44%
Loosely correlated
-2.15%
RLAY - KRRO
42%
Loosely correlated
+6.38%
TRDA - KRRO
41%
Loosely correlated
-0.51%
More